HBK Investments’s iShares Biotechnology ETF IBB Stock Holding History

HBK Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,300	Closed	-$1M	–	248
2019 Q4	$1M	Buy	+8,300	New	+$926K	0.01%	506
2019 Q2	–	Sell	-42,000	Closed	-$4.7M	–	822
2019 Q1	$4.7M	Buy	+42,000	New	+$4.61M	0.05%	336
2018 Q3	–	Sell	-13,500	Closed	-$1.48M	–	1251
2018 Q2	$1.48M	Buy	+13,500	New	+$1.44M	0.01%	545

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

HBK Investments's IBB Position: Q1 2020 in Review

HBK Investments sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 8,300 shares — an estimated $1M sold.

HBK Investments first reported a position in IBB in Q2 2018 and held it in 3 quarters. The position peaked at $4.7M in Q1 2019. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

HBK Investments reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
HBK Investments sold 8,300 iShares Biotechnology ETF shares in Q1 2020, an estimated $1M.
HBK Investments first reported a position in iShares Biotechnology ETF in Q2 2018 and held it in 3 quarters.
HBK Investments's iShares Biotechnology ETF position peaked at $4.7M in Q1 2019.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.